and recommendation
Regenxbio Inc. (RGNX)
RGNX is focused on developing, commercializing and licensing recombinant adeno-associated virus gene therapy with a proprietary delivery platform to treat rare diseases. RGNX is commercializing gene therapy products administered directly into the body, or in vivo, based on a NAV Technology Platform. Its NAV Technology Platform is currently being applied in the development of 23 product candidates for a variety of diseases, Regenxbio said, with exclusive rights to over 100 patents and patent applications worldwide.
- April 2, 2024 - 3:16pm | Out and About, Research Notes, Out and About, Earnings, Earnings Q3
- March 6, 2024 - 5:37pm | Out and About, Research Notes, Out and About, Financings
- February 20, 2024 - 11:49am | Out and About, Research Notes, Out and About, Earnings Alert, Earnings, Earnings Q3
- August 18, 2023 - 4:09pm | Out and About, Research Notes, Out and About, Earnings Alert, Earnings
- July 31, 2023 - 7:19am | Out and About, Research Notes, Out and About, Earnings Alert, Earnings, Earnings Q2
- May 27, 2023 - 12:37pm | Out and About, Research Notes, Out and About, Earnings Alert, Earnings, Earnings Q1
- April 10, 2023 - 4:40pm | Out and About, Research Notes, Out and About, Earnings, Earnings Q4
- August 16, 2022 - 11:38am | Out and About, Research Notes, Out and About
- September 23, 2021 - 7:10pm | Out and About, Research Notes, Out and About, Earnings Q2
- January 12, 2021 - 5:32pm | Out and About, Research Notes, Out and About, Financings
- May 30, 2020 - 9:44am | Out and About, Research Notes, Out and About, Earnings Q1
- April 11, 2020 - 1:23pm | Out and About, Research Notes, Out and About, Earnings, Earnings Q4
- November 3, 2019 - 2:45pm | Out and About, Research Notes, Out and About, Earnings
- January 8, 2019 - 1:13pm | Out and About, Out and About
- November 8, 2018 - 2:20pm | Out and About, Research Notes, Out and About, Earnings
- September 11, 2018 - 1:18pm | Out and About, Research Notes, Out and About, Earnings, Earnings Q2
- August 8, 2018 - 7:28pm | Research Notes, Financings
- June 2, 2018 - 7:11am | Out and About, Out and About, Earnings, Earnings Q1
- April 9, 2018 - 9:11am | Analysis, Research Notes
- March 10, 2018 - 9:22am | Earnings, Earnings Q4